NPI registry status
Active
2026 NPPES data Ophthalmology Physician NPI 1033271317 M.D.
Verify on CMS → Donald Peavy, M.D.
Ophthalmology Physician in Baton Rouge, Louisiana.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 22,388 in Ophthalmology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 630 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
47%
generic claims · 53% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
23.9/100
▼ 60 pts below national avg 83.5 · Below average
Industry payments
$230.35
7 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Donald Peavy, M.D. reported a CMS MIPS final score of 23.9/100 - below the 83.5 national average - and filed 2,472 Medicare Part D claims in 2024.
- 23.9/100
- MIPS score · -60 vs avg
- 2K
- Part D claims, 2024
- 47%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Donald Peavy, M.D.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1033271317), first enumerated 12/14/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 2,472 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 23.9/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$230.35 in reported industry payments (7 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1033271317 · Ophthalmology Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-LOW · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1033271317
- ENUM-LEGACY 2006
- TAX-MID 22K Ophthalmology Physician
- MIPS-LOW 23.9/100
- RX-MID 2,472
- BOOK-THIN 312 in Louisiana
- PHOTO-FINISH Mitchell Shultz, M.D. · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Stephen Pollack,…
Stephen Pollack, MD
23.8 MIPS pts
- Peavy · this pro…
Peavy · this provider
23.9 MIPS pts
- Scott So, M.D. ·…
Scott So, M.D.
23.9 MIPS pts
- Mitchell Shultz,…
Mitchell Shultz, M.D.
23.9 MIPS pts
- Farshid Ighani, …
Farshid Ighani, MD
24 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Donald Peavy, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
24 ≥ 3rd percentile 3% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Donald Peavy, M.D. sits
This provider among ophthalmology physician peers
Across the 8,767 ophthalmology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Donald Peavy, M.D. writes more Part D claims than 80% of them and scores higher on MIPS quality than 5% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one ophthalmology physician peer from a representative sample of 60; the gold marker is Donald Peavy, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Donald Peavy, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Donald Peavy, M.D.?
Below national averagePrimary specialty
Ophthalmology Physician
Medicare Part D claims
2,472 66% vs specialty avg
MIPS final score
23.9/100 59.6 pts vs avg
Specialty distribution in Louisiana
How Ophthalmology Physician compares to other specialties among Louisiana providers
Medicare quality performance, MIPS
Donald Peavy, M.D.'s 2023 MIPS final score plotted against the Ophthalmology Physician national average
- MIPS Final Score
- 23.9/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1033271317 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 12/14/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
23.8856
Final Score
Measured-score avg: 83.5
0
Quality
79.6186
Cost
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Donald Peavy, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$230
Largest payer
Alcon Vision LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
Donald Peavy, M.D. - brand share 53.0%
Ophthalmology Physician average
53% brand-name claims vs 47% generic, on 2,472 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
2,472
Total Claims
$218K
Total Drug Cost
630
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 3,593.7
- Total Day Supply
- 93,809
- Brand vs Generic
- 53% brand / 47% generic
- Brand Drug Cost
- $186K
- Generic Drug Cost
- $32K
Patient Demographics
- Average Patient Age
- 74.5 years
- Avg HCC Risk Score
- 1.48
- Gender Split
- 65% female / 35% male
- Age Distribution
- <65: 50, 65-74: 276, 75-84: 223, 85+: 81
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Donald Peavy, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Latanoprost
Latanoprost
554 claims
- Prednisolone Acetate
Prednisolone Acetate
441 claims
- Dorzolamide-Timolol
Dorzolamide-Timolol
235 claims
- Timolol Maleate 168
Timolol Maleate
168 claims
- Ketorolac Trometha… 167
Ketorolac Tromethamine
167 claims
- Tobramycin-Dexamet… 155
Tobramycin-Dexamethasone
155 claims
- Neomycin-Polymyxin… 138
Neomycin-Polymyxin-Dexameth
138 claims
- Travoprost 71
Travoprost
71 claims
| Drug | Claims |
|---|---|
| Latanoprost | 554 |
| Prednisolone Acetate | 441 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 235 |
| Timolol Maleate | 168 |
| Ketorolac Tromethamine | 167 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 155 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 138 |
| Travoprost | 71 |
| Ilevro Nepafenac | 63 |
| Lumigan Bimatoprost | 62 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How Donald Peavy, M.D. fits within the Ophthalmology Physician landscape nationally.
22,388
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,490
Avg Claims per Provider
Donald Peavy, M.D.'s 2,472 claims are above the specialty average of 1,490.
Nationwide Ophthalmology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Peavy, both outside Louisiana so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (23.9 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Ophthalmology Physician Providers in Louisiana
Other clinicians with the same primary specialty enrolled in Louisiana, drawn from the same CMS NPPES roster as Peavy.
One of 312 Ophthalmology Physician providers enrolled in Louisiana, 5 are shown here.
Dr. Kyle Acosta
MD
Covington, LA
Dr. Charles Afeman
MD
Baton Rouge, LA
Lena Al-Dujaili
New Orleans, LA
Dr. Richard Apt
M.D.
Monroe, LA
Dr. Richard Arceneaux
M.D.
Thibodaux, LA
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Donald Peavy, M.D.'s specialty? ▼
Donald Peavy, M.D. specializes in Ophthalmology Physician and practices in Baton Rouge, Louisiana. Credentials: M.D..
How much does Donald Peavy, M.D. prescribe under Medicare Part D? ▼
In 2024, Donald Peavy, M.D. wrote 2,472 Medicare Part D claims totaling $218K in drug costs for 630 beneficiaries.
What is Donald Peavy, M.D.'s Medicare quality score? ▼
Donald Peavy, M.D. has a CMS MIPS Final Score of 23.9/100 (Quality: 0, Cost: 79.6). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Donald Peavy, M.D. located? ▼
Donald Peavy, M.D. is located at 4848 NORTH BLVD, Baton Rouge, LA, 70806. Phone: (225) 927-0180.
What is Donald Peavy, M.D.'s NPI number? ▼
Donald Peavy, M.D.'s National Provider Identifier (NPI) is 1033271317, issued on 12/14/2006.
Does Donald Peavy, M.D. prescribe more brand-name or generic drugs? ▼
Donald Peavy, M.D.'s prescribing is 53% brand-name and 47% generic drugs by claim count, with $186K in brand drug costs.
How many Ophthalmology Physician providers are there in the US? ▼
There are 22,388 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,490 Medicare Part D claims per year.
What drugs does Donald Peavy, M.D. prescribe most often? ▼
Based on 2024 Medicare Part D data, Donald Peavy, M.D.'s most frequently prescribed drugs include Latanoprost, Prednisolone Acetate, Dorzolamide-Timolol. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Donald Peavy, M.D. accept Medicare? ▼
Donald Peavy, M.D. appears in CMS Medicare data with 2,472 Part D claims and 630 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Donald Peavy, M.D.'s credentials? ▼
Donald Peavy, M.D.'s NPI is 1033271317 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.